A detailed history of Engineers Gate Manager LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,287 shares of QURE stock, worth $247,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,287
Holding current value
$247,879
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.78 - $10.12 $54,004 - $144,584
14,287 New
14,287 $70,000
Q1 2024

May 15, 2024

SELL
$4.82 - $6.93 $59,170 - $85,072
-12,276 Reduced 24.17%
38,518 $200,000
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $67,503 - $99,157
11,990 Added 30.9%
50,794 $343,000
Q3 2023

Nov 14, 2023

SELL
$6.71 - $11.83 $25,518 - $44,989
-3,803 Reduced 8.93%
38,804 $260,000
Q2 2023

Aug 14, 2023

BUY
$11.12 - $22.2 $473,789 - $945,875
42,607 New
42,607 $488,000
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $365,570 - $568,510
27,800 New
27,800 $518,000
Q1 2022

May 16, 2022

SELL
$14.54 - $21.5 $251,745 - $372,251
-17,314 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$20.24 - $36.01 $350,435 - $623,477
17,314 New
17,314 $359,000
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $787,010 - $1.16 Million
-30,258 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $906,832 - $1.12 Million
30,258 New
30,258 $932,000
Q1 2021

May 17, 2021

SELL
$29.24 - $42.03 $997,727 - $1.43 Million
-34,122 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$35.35 - $50.67 $614,241 - $880,441
17,376 Added 103.76%
34,122 $1.23 Million
Q3 2020

Nov 16, 2020

SELL
$35.98 - $47.66 $161,802 - $214,327
-4,497 Reduced 21.17%
16,746 $617,000
Q2 2020

Aug 17, 2020

BUY
$45.06 - $67.74 $156,718 - $235,599
3,478 Added 19.58%
21,243 $957,000
Q1 2020

May 15, 2020

BUY
$40.01 - $73.97 $710,777 - $1.31 Million
17,765 New
17,765 $843,000
Q4 2019

Feb 14, 2020

SELL
$37.13 - $74.62 $260,392 - $523,310
-7,013 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$39.36 - $76.8 $276,031 - $538,598
7,013 New
7,013 $276,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $811M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.